A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in patients with an aggressive subtype of triple-negative breast cancer.
Newswise: Latest News
Researchers Identify Rb1 as a Predictive Biomarker for a New Therapeutic Strategy in Some Breast Cancers
December 25, 2025By
